Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
about
Predicting the risk for dialysis or death in IgA nephropathy.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseasesCombined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients.High dose Losartan and ACE gene polymorphism in IgA nephritis.Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model miceCirculating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans.Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy.Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis.Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria.
P2860
Q34726899-E54D53A8-8009-4D5A-891E-1741642B9796Q35995685-16F8691D-57D8-4C39-A0B9-E760E3160AE2Q36116868-78E684DD-9C5E-46E4-996A-6C83674190AAQ36480076-F95E7577-1768-46F6-B4A8-F04BC2042BC0Q36565036-72C0DAB2-CB62-4861-B98F-6C521A719903Q37069308-C938F1F3-8365-41BD-9626-356136148DACQ37223733-A469DE22-3A49-424F-B613-1040B1B04ADFQ37307052-9C2A9F13-D4E4-43B3-96DC-B10064F873BFQ37444586-A0D72361-9431-4CCB-AF7D-A01AE8C1F69DQ37471445-0BEF89C1-9D90-4629-A60A-31C1036D5D15Q41862960-289DCBDC-D6D0-48C0-B63C-55BA9BA097B8Q41993059-B34E2E37-3652-4564-B3FC-CAB5FBE25E02Q45934007-8C84A71A-CECA-4D62-813B-0B5DE5A7F163Q50523800-58833D05-53DC-42DA-8EF3-DC5B48297153Q51595672-2B35B694-9FD1-4E57-964E-A0133EB59066
P2860
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@ast
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@en
type
label
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@ast
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@en
prefLabel
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@ast
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@en
P1476
Angiotensin-converting enzyme ...... blockers for IgA nephropathy.
@en
P2093
John J Dillon
P304
P356
10.1016/J.SEMNEPHROL.2004.01.003
P577
2004-05-01T00:00:00Z